Covid-19: Maharashtra to procure Remdesivir, Favipiravir in large numbers
The drugs are costly so the state has decided to buy them itself
 "Covid-19: Maharashtra to procure Remdesivir, Favipiravir in large numbers")
premium
The Maharashtra government has decided to procure anti-viral drugs Remdesivir and Favipiravir in large quantities for the treatment of Covid-19 patients, state health minister Rajesh Tope said on Thursday.
"We have decided to buy Remdesivir and Favipiravir as well as other essential drugs to treat Covid-19 patients in large numbers. The drugs are costly so the state has decided to buy them itself," he told reporters here.
"We are also asking district collectors to requisition private ambulances for transportation of Covid-19 patients. Every district has a fixed rate of transportation. Ambulance operators can be paid accordingly," Tope said.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%